Enhanced IT Propels Clinical Laboratory Services Sector
|
By LabMedica International staff writers Posted on 26 Oct 2015 |
Fueled by new information technology (IT) software that allows laboratories to test in new ways, the USD 102 billion global market for clinical laboratory services is rapidly growing and evolving, according to a new healthcare market report. The growing number of laboratories offering specialty testing is an indication of such advancements in the industry.
The new report “Clinical Laboratory Services Market” by Kalorama Information (New York, NY, USA) provides an in-depth overview and total market analysis including routine and specialty testing, analysis by laboratory type, and a review of the latest trends driving growth, including new developments being pursued in genomics and proteomics that will likely result in more advanced testing and a better understanding of diseases.
“Several new technologies have streamlined the clinical laboratory industry,” said Bruce Carlson, publisher, Kalorama Information, “Leading healthcare IT companies now offer laboratory management software designed to easily manage the day-to-day activities.” For example, Cerner Corporation’s “Millennium PathNet General Laboratory Software” has been implemented in several large national accounts — improving turnaround times and laboratory efficiency. Advanced software, wireless technologies, and growth in implementation have allowed for easy access to lab results, including remote access for physicians, billing staff, and patients.
Efficiently communicating results with clients is essential and may be as important as providing leading test menus in cutting-edge areas. In an evolving effort to more efficiently connect with patients and physicians, several laboratories have developed electronic test result distribution. This is not a novel concept but it has been an area of focus over the past few years, especially as new electronic technologies and the internet are used extensively.
Quest Diagnostics developed an app to allow patients to access their results via smartphone. This app also supports other health information, including storing immunization and other medical records, vital health stats, various healthcare providers’ contact information, as well as names and numbers of prescriptions, their dosages, and allergies to foods or medications. Such data provide convenient access and could prove invaluable in a health emergency. An important consideration is patient confidentiality, the connection to patient records must be highly secure and granted only to the correct parties.
Kalorama’s report provides key market data for tissue pathology, routine chemistry testing, non-tissue molecular testing, toxicology/drug abuse testing, as well as statistics for hospital, physician, and independent labs, and the major tests performed by clinical lab companies. Information and forecast is presented as a United States-focused report, with general worldwide data and a section on key international markets including Europe, Asian Pacific, and Latin America. Historical data is provided for the years 2010 through 2014, with forecast data provided for 2016 through 2020. Information was gathered using both primary and secondary research, including interviews with over 50 key industry officials, consultants, health care providers, and government personnel.
Related Links:
Kalorama Information
Clinical Laboratory Services Market, report
The new report “Clinical Laboratory Services Market” by Kalorama Information (New York, NY, USA) provides an in-depth overview and total market analysis including routine and specialty testing, analysis by laboratory type, and a review of the latest trends driving growth, including new developments being pursued in genomics and proteomics that will likely result in more advanced testing and a better understanding of diseases.
“Several new technologies have streamlined the clinical laboratory industry,” said Bruce Carlson, publisher, Kalorama Information, “Leading healthcare IT companies now offer laboratory management software designed to easily manage the day-to-day activities.” For example, Cerner Corporation’s “Millennium PathNet General Laboratory Software” has been implemented in several large national accounts — improving turnaround times and laboratory efficiency. Advanced software, wireless technologies, and growth in implementation have allowed for easy access to lab results, including remote access for physicians, billing staff, and patients.
Efficiently communicating results with clients is essential and may be as important as providing leading test menus in cutting-edge areas. In an evolving effort to more efficiently connect with patients and physicians, several laboratories have developed electronic test result distribution. This is not a novel concept but it has been an area of focus over the past few years, especially as new electronic technologies and the internet are used extensively.
Quest Diagnostics developed an app to allow patients to access their results via smartphone. This app also supports other health information, including storing immunization and other medical records, vital health stats, various healthcare providers’ contact information, as well as names and numbers of prescriptions, their dosages, and allergies to foods or medications. Such data provide convenient access and could prove invaluable in a health emergency. An important consideration is patient confidentiality, the connection to patient records must be highly secure and granted only to the correct parties.
Kalorama’s report provides key market data for tissue pathology, routine chemistry testing, non-tissue molecular testing, toxicology/drug abuse testing, as well as statistics for hospital, physician, and independent labs, and the major tests performed by clinical lab companies. Information and forecast is presented as a United States-focused report, with general worldwide data and a section on key international markets including Europe, Asian Pacific, and Latin America. Historical data is provided for the years 2010 through 2014, with forecast data provided for 2016 through 2020. Information was gathered using both primary and secondary research, including interviews with over 50 key industry officials, consultants, health care providers, and government personnel.
Related Links:
Kalorama Information
Clinical Laboratory Services Market, report
Latest Industry News
- AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
- New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
- Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
- WHX Labs Dubai to Gather Global Experts in Antimicrobial Resistance at Inaugural AMR Leaders’ Summit
- BD and Penn Institute Collaborate to Advance Immunotherapy through Flow Cytometry
- Abbott Acquires Cancer-Screening Company Exact Sciences
- Roche and Freenome Collaborate to Develop Cancer Screening Tests
- Co-Diagnostics Forms New Business Unit to Develop AI-Powered Diagnostics
- Qiagen Acquires Single-Cell Omics Firm Parse Biosciences
- Puritan Medical Products Showcasing Innovation at AMP2025 in Boston
- Advanced Instruments Merged Under Nova Biomedical Name
- Bio-Rad and Biodesix Partner to Develop Droplet Digital PCR High Complexity Assays
- Hologic to be Acquired by Blackstone and TPG
- Bio-Techne and Oxford Nanopore to Accelerate Development of Genetics Portfolio
- Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders
- Revvity and Sanofi Collaborate on Program to Revolutionize Early Detection of Type 1 Diabetes
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreMolecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read moreAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more







